Canada · How much has NervGen Pharma raised?
NervGen Pharma has raised $60M across 1 round since 2026.
Canada · Funded startup
Who invested in NervGen Pharma
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 7 months ago
Follow NervGen Pharma and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$60Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $60MMay 2026
- Investors
- 0
The rounds
- May 2026Round$60M
No investor was named in the report.
Source recorded
Founders and team
From NervGen Pharma's own website: 6 on the team.
- Shamim RuffChief Regulatory Affairs Officer
- Brian BayleyDirector
- Craig ThompsonDirector
- John RuffoloDirector
- Krista McKerracherDirector
- Neil KlompasDirector
Quick answers about NervGen Pharma
When did NervGen Pharma last raise?
NervGen Pharma's most recent round was an Undisclosed round of $60M in May 2026.
What was NervGen Pharma's biggest round?
Its most recent round, $60M in May 2026, is also its largest on record.
What stage is NervGen Pharma at?
NervGen Pharma's latest named round is an Undisclosed round, in May 2026.
Where is NervGen Pharma based?
NervGen Pharma is based in Canada.
Companies like NervGen Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.